Keywords: 4th-qtr, charges, hit, genzyme, general, company, reported
4th-qtr charges hit Genzyme General
Article | 17 March 2003
US company Genzyme General has reported a 12% increase infourth-quarter 2002 revenues to $298.0 million, and net income down 1.1% at $44.7 million, or $0.20 per ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
